Want to see JP:9987 full AI Analyst Report?

Suzuken Co (9987) Price & Analysis

0 Followers

9987 Stock Chart & Stats

¥6337.00

-¥26.00(-0.55%)

At close: Jan 08 4:00 PM EST

¥6337.00

-¥26.00(-0.55%)

Day’s Range― - ―

52-Week Range¥4,810.00 - ¥6,668.00

Previous CloseN/A

Volume197.40K

Average Volume (3M)163.97K

Market Cap

¥280.99B

Enterprise Value¥219.80B

Total Cash (Recent Filing)¥142.20B

Total Debt (Recent Filing)¥23.85B

Price to Earnings (P/E)9.1

Beta0.35

Next Earnings

Aug 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.6%

Share Statistics

EPS (TTM)440.22

Shares Outstanding72,167,206

10 Day Avg. Volume143,650

30 Day Avg. Volume163,966

Financial Highlights & Ratios

PEG Ratio0.54

Price to Book (P/B)1.00

Price to Sales (P/S)0.17

P/FCF Ratio22.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥7,100.00

Price Target Upside12.04% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)378.6

Revenue Forecast (FY)¥2.55T

Bulls Say, Bears Say

Bulls Say

Very Conservative Balance SheetNear-zero debt and a large, stable equity base materially reduce financial risk, preserving flexibility to invest in logistics, absorb shocks, and sustain operations. This durable low-leverage profile supports long-term resilience and strategic optionality.

Steady Revenue Growth And Improving ProfitsConsistent mid-single-digit revenue growth paired with multiyear profit improvement indicates structural business momentum and better cost or mix management. This trend supports sustainable earnings potential and increased operating leverage over time.

Scale And Logistics-focused Distribution ModelA high-frequency, scale-driven wholesale model creates durable advantages: logistics expertise, supplier relationships, and inventory infrastructure reduce unit costs and raise switching costs for customers, supporting steady revenue flows in the medical distribution niche.

Bears Say

Volatile Cash GenerationLarge year-to-year swings in operating and free cash flow indicate working-capital sensitivity and inconsistent cash conversion. This reduces predictability for capex, dividends, and M&A, increasing execution risk for multi-quarter strategic plans.

Structurally Thin MarginsLow absolute margins inherent to wholesale distribution limit earnings leverage and make profitability more vulnerable to input cost inflation, reimbursement changes, or competitive pressure, constraining long-term ROE expansion.

Recent Cost Pressure On Operating ProfitsAn EBIT decline despite revenue growth signals potential structural cost or efficiency issues. If persistent, rising operating costs will erode the modest margin base and hinder the company's ability to sustain profit improvements.

Suzuken Co News

Suzuken to Grant Restricted Treasury Shares as Long-Term Executive Incentive

Suzuken Co ( ($JP:9987) ) just unveiled an announcement. Suzuken has approved the disposal of 36,366 treasury shares...

14d ago

Suzuken Boosts Shareholder Returns With Higher Dividend and New Payout Policy

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken has approved a new shareholder return policy that...

2M ago

Suzuken to Implement Two-for-One Stock Split to Broaden Investor Base

An announcement from Suzuken Co ( ($JP:9987) ) is now available. Suzuken’s board has approved a two-for-one stock...

2M ago

Suzuken Unveils Medium-Term Plan to Build Next-Generation Pharmaceutical Distribution Model

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken has unveiled a three-year Medium-Term Management Plan running...

2M ago

Suzuken lifts profit and maintains dividend as it prepares stock split and softer earnings outlook

Suzuken Co ( ($JP:9987) ) has issued an update. Suzuken reported consolidated net sales of ¥2.49 trillion for...

2M ago

Suzuken Completes ¥26 Billion Share Buyback Program

Suzuken Co ( ($JP:9987) ) has shared an update. Suzuken has completed a share repurchase program authorized in...

4M ago

Suzuken Nears Completion of ¥26 Billion Share Buyback Program

The latest announcement is out from Suzuken Co ( ($JP:9987) ). Suzuken has provided an update on its...

4M ago

Suzuken Reshapes Pharmaceutical Logistics with Intra-Group Split and New Subsidiary

Suzuken Co ( ($JP:9987) ) has provided an announcement. Suzuken will restructure its intra-group logistics operations by carving...

5M ago

Suzuken posts higher sales but weaker profits and lower equity ratio for nine months

Suzuken Co ( ($JP:9987) ) has issued an announcement. Suzuken reported consolidated net sales of ¥1.89 trillion for...

5M ago

Suzuken Updates Progress on Ongoing Share Repurchase Program

An announcement from Suzuken Co ( ($JP:9987) ) is now available. Suzuken Co., Ltd. reported the January 2026...

5M ago

Suzuken upgraded to Buy from Hold at Jefferies

Jefferies upgraded Suzuken to Buy from Hold with a price target of 5,900 yen, up from 5,200 yen....

2y ago

Suzuken downgraded to Neutral from Buy at Citi

Citi downgraded Suzuken to Neutral from Buy with a price target of 5,200 yen, up from 4,800 yen....

3y ago

SZUKF

9987 FAQ

What was Suzuken Co Ltd’s price range in the past 12 months?

Suzuken Co Ltd lowest stock price was ¥4810.00 and its highest was ¥6668.00 in the past 12 months.

What is Suzuken Co Ltd’s market cap?

Suzuken Co Ltd’s market cap is ¥280.99B.

When is Suzuken Co Ltd’s upcoming earnings report date?

Suzuken Co Ltd’s upcoming earnings report date is Aug 12, 2026 which is in 36 days.

How were Suzuken Co Ltd’s earnings last quarter?

Suzuken Co Ltd released its earnings results on May 14, 2026. The company reported ¥105.8 earnings per share for the quarter, beating the consensus estimate of ¥62.144 by ¥43.656.

Is Suzuken Co Ltd overvalued?

According to Wall Street analysts Suzuken Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Suzuken Co Ltd pay dividends?

Suzuken Co Ltd pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 1.6%. See more information on Suzuken Co Ltd dividends here

What is Suzuken Co Ltd’s EPS estimate?

Suzuken Co Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Suzuken Co Ltd have?

Suzuken Co Ltd has 72,167,206 shares outstanding.

What happened to Suzuken Co Ltd’s price movement after its last earnings report?

Suzuken Co Ltd reported an EPS of ¥105.8 in its last earnings report, beating expectations of ¥62.144. Following the earnings report the stock price went down -5.105%.

Which hedge fund is a major shareholder of Suzuken Co Ltd?

Currently, no hedge funds are holding shares in JP:9987

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suzuken Co Ltd

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.

Suzuken Co (9987) Earnings & Revenues

Historic Earnings Reports

9987 Stock 12 Month Forecast

Average Price Target

¥7,100.00

▲(12.04% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4863":"¥4,863","5982":"¥5,982","7101":"¥7,101","5422.5":"¥5,422.5","6541.5":"¥6,541.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥7K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4863,5422.5,5982,6541.5,7101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4864,5036,5208,5380,5552,5724,5896,6068,6240,6412,6584,6756,6928,{"y":7100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4864,5036,5208,5380,5552,5724,5896,6068,6240,6412,6584,6756,6928,{"y":7100,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4864,5036,5208,5380,5552,5724,5896,6068,6240,6412,6584,6756,6928,{"y":7100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5112.411,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5660.029,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5862.559,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5769.516,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5806.208,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5935.125,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6079.908,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6180.067,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6529.133,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6110,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5497,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5124,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4864,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >